feed,title,long_url,short_url
BioRxiv,Computational prediction of SARS-CoV-2 encoded miRNAs and their putative host targets,https://biorxiv.org/cgi/content/short/2020.11.02.365049v1?rss=1,https://j.mp/3jX4C73
BioRxiv,Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design,https://biorxiv.org/cgi/content/short/2020.11.03.366609v1?rss=1,https://j.mp/2JA6RRi
BioRxiv,"COVID-19 risk haplogroups differ between populations, deviate from Neanderthal haplotypes and compromise risk assessment in non-Europeans",https://biorxiv.org/cgi/content/short/2020.11.02.365551v1?rss=1,https://j.mp/2TTdrnT
BioRxiv,Potential Opportunity Of Antisense Therapy Of COVID-19 on an in vitro model,https://biorxiv.org/cgi/content/short/2020.11.02.363598v1?rss=1,https://j.mp/364suAy
BioRxiv,Antiviral activity of plant juices and green tea against SARS-CoV-2 and influenza virus in vitro,https://biorxiv.org/cgi/content/short/2020.10.30.360545v1?rss=1,https://j.mp/34ReNFT
BioRxiv,Structure of nonstructural protein 1 from SARS-CoV-2,https://biorxiv.org/cgi/content/short/2020.11.03.366757v1?rss=1,https://j.mp/3oSwJrG
BioRxiv,Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate,https://biorxiv.org/cgi/content/short/2020.11.03.366138v1?rss=1,https://j.mp/2Gu1JNs
BioRxiv,Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants,https://biorxiv.org/cgi/content/short/2020.11.02.364729v1?rss=1,https://j.mp/3872gQC
